Pasithea Therapeutics Corp (KTTA)
7.15
+0.65
(+10.00%)
USD |
NASDAQ |
May 17, 16:00
7.15
0.00 (0.00%)
After-Hours: 20:00
Pasithea Therapeutics 1 Year Total Returns (Daily): -2.97% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -2.97% |
| May 16, 2024 | -4.44% |
| May 15, 2024 | -5.03% |
| May 14, 2024 | -5.94% |
| May 13, 2024 | -1.70% |
| May 10, 2024 | 6.40% |
| May 09, 2024 | 7.71% |
| May 08, 2024 | -0.56% |
| May 07, 2024 | 8.03% |
| May 06, 2024 | 8.03% |
| May 03, 2024 | 0.12% |
| May 02, 2024 | -3.89% |
| May 01, 2024 | 4.25% |
| April 30, 2024 | -1.11% |
| April 29, 2024 | -1.11% |
| April 26, 2024 | -3.13% |
| April 25, 2024 | -9.73% |
| April 24, 2024 | -21.06% |
| April 23, 2024 | -17.37% |
| April 22, 2024 | -21.21% |
| April 19, 2024 | -14.34% |
| April 18, 2024 | -14.37% |
| April 17, 2024 | -6.39% |
| April 16, 2024 | -7.08% |
| April 15, 2024 | -8.36% |
| Date | Value |
|---|---|
| April 12, 2024 | -5.23% |
| April 11, 2024 | -3.77% |
| April 10, 2024 | 1.26% |
| April 09, 2024 | 3.07% |
| April 08, 2024 | 5.62% |
| April 05, 2024 | 8.95% |
| April 04, 2024 | 9.40% |
| April 03, 2024 | -0.12% |
| April 02, 2024 | -3.61% |
| April 01, 2024 | -3.33% |
| March 28, 2024 | -7.07% |
| March 27, 2024 | -12.80% |
| March 26, 2024 | -8.75% |
| March 25, 2024 | -10.86% |
| March 22, 2024 | -23.84% |
| March 21, 2024 | -17.19% |
| March 20, 2024 | -19.41% |
| March 19, 2024 | -20.70% |
| March 18, 2024 | -17.27% |
| March 15, 2024 | -25.83% |
| March 14, 2024 | -22.25% |
| March 13, 2024 | -19.20% |
| March 12, 2024 | -25.38% |
| March 11, 2024 | -22.54% |
| March 08, 2024 | -28.52% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.79%
Minimum
Nov 23 2022
9.40%
Maximum
Apr 04 2024
-50.57%
Average
-55.66%
Median
Nov 22 2022
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -52.96% |
| AIM ImmunoTech Inc | -19.40% |
| IGC Pharma Inc | 69.70% |
| NovaBay Pharmaceuticals Inc | -83.53% |
| Protalix BioTherapeutics Inc | -51.69% |